Inocras
PrivateLast Round
Series B
Extension
Nov 1, 2023
Total Funding Raised
$51.96M
Momentum Score
25 /100
Company Overview
Inocras is a biotechnology company that provides an AI-driven platform offering whole genome insights to enable personalized care in cancer and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inocras Comps
Public and private peers based on sector, stage, and business model.
Inocras Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Nov 1, 2023 | ||||
| Series B | Apr 28, 2022 | ||||
| Series A | Dec 1, 2020 |
Key People
Founding team and executive leadership
Inocras Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InterVest | Series B |
| DSC Investment | Series A, Series B |
| Paratus Investment | Series A, Series B |
| Dunamu & Partners | Series B |
| Signite Partners | Series B |
| Timefolio Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
Will present TCGA cancer whole-genome analysis at AACR Annual Meeting 2026.
- Mar 12, 2026
Partnered with NDS Corporation, an IT services provider specializing in healthcare data and cloud solutions.
Inocras Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inocras's valuation, stock price, and market status.
